Becton Dickinson and Company Profile (NYSE:BDX)

About Becton Dickinson and

Becton Dickinson and logoBecton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company operates through two business segments: BD Medical, which consists of Diabetes Care, Medication and Procedural Solutions, Medication Management Solutions, Pharmaceutical Systems and Respiratory Solutions business units, and BD Life Sciences, which consists of Preanalytical Systems, Diagnostic Systems and Biosciences business units. The Company's products include hypodermic needles and syringes; insulin syringes and pen needles; BD Hypak brand prefillable syringe systems; infusion therapy products, including Alaris infusion pumps; BD Vacutainer brand blood collection products, and flow cytometry instruments and reagents.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BDX
  • CUSIP: 07588710
Key Metrics:
  • Previous Close: $174.14
  • 50 Day Moving Average: $174.73
  • 200 Day Moving Average: $162.58
  • Trailing P/E Ratio: 33.49
  • Foreward P/E Ratio: 18.53
  • P/E Growth: 1.52
  • Market Cap: $37.36B
  • Outstanding Shares: 212,925,000
  • Beta: 0.95
Additional Links:
Companies Related to Becton Dickinson and:

Analyst Ratings

Consensus Ratings for Becton Dickinson and (NYSE:BDX) (?)
Ratings Breakdown: 6 Hold Ratings, 8 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $169.67 (3.31% downside)

Analysts' Ratings History for Becton Dickinson and (NYSE:BDX)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016Cowen and CompanyReiterated RatingOutperform$185.00View Rating Details
8/9/2016Leerink SwannReiterated RatingHoldView Rating Details
8/5/2016Jefferies GroupReiterated RatingBuyView Rating Details
7/12/2016Bank of America Corp.Reiterated RatingBuyView Rating Details
6/12/2016ArgusReiterated RatingBuyView Rating Details
6/1/2016Evercore ISIDowngradeBuy -> HoldView Rating Details
5/9/2016Royal Bank Of CanadaBoost Price TargetSector Perform$153.00 -> $169.00View Rating Details
5/8/2016Morgan StanleyReiterated RatingHoldView Rating Details
5/3/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
4/8/2016Goldman Sachs Group Inc.Boost Price Target$156.00 -> $157.00View Rating Details
2/11/2016Deutsche Bank AGUpgradeHold -> Buy$155.00 -> $163.00View Rating Details
2/4/2016Citigroup Inc.Lower Price TargetNeutral$153.00 -> $146.00View Rating Details
12/11/2015Raymond James Financial Inc.Boost Price TargetStrong-Buy$172.00 -> $176.00View Rating Details
11/22/2015Piper Jaffray Cos.Reiterated RatingOverweight$160.00 -> $171.00View Rating Details
11/19/2015William BlairReiterated RatingOutperformView Rating Details
7/2/2015Barclays PLCReiterated RatingEqual Weight$158.00 -> $158.00View Rating Details
5/7/2015Canaccord GenuitySet Price TargetHold$145.00View Rating Details
1/9/2015SunTrust Banks Inc.DowngradeBuy -> NeutralView Rating Details
10/7/2014Stifel NicolausUpgradeHold -> Buy$153.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Becton Dickinson and (NYSE:BDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/4/2016Q316$2.21$2.35$3.21 billion$3.20 billionViewListenView Earnings Details
5/5/2016Q216$2.02$2.18$3.07 billion$3.07 billionViewListenView Earnings Details
2/3/2016Q116$1.84$1.96$3.04 billion$2.99 billionViewListenView Earnings Details
11/4/2015Q415$1.90$1.94$3.04 billion$3.07 billionViewListenView Earnings Details
8/6/2015Q315$2.01$2.05$3.13 billion$3.12 billionViewListenView Earnings Details
5/7/2015Q2$1.53$1.61$2.05 billion$2.05 billionViewListenView Earnings Details
2/5/2015Q115$1.45$1.53$2.04 billion$2.05 billionViewListenView Earnings Details
11/4/2014Q414$1.66$1.68$2.16 billion$2.20 billionViewListenView Earnings Details
7/31/2014Q314$1.67$1.65$2.14 billion$2.16 billionViewListenView Earnings Details
5/1/2014Q2$1.50$1.45$2.09 billion$2.07 billionViewListenView Earnings Details
2/4/2014Q114$1.30$1.42$1.98 billion$2.00 billionViewListenView Earnings Details
11/5/2013Q413$1.46$1.52$2.05 billion$2.10 billionViewListenView Earnings Details
8/1/2013Q3 2013$1.48$1.58$2.05 million$2.05 billionViewListenView Earnings Details
5/2/2013Q2 2013$1.35$1.44$1.99 billion$2.00 billionViewListenView Earnings Details
2/5/2013Q1 2013$1.24$1.35$1.86 billion$1.90 billionViewListenView Earnings Details
11/7/2012Q412$1.40$1.42$1.96 billion$1.97 billionViewN/AView Earnings Details
8/2/2012$1.53$1.52ViewN/AView Earnings Details
5/1/2012$1.38$1.38ViewN/AView Earnings Details
2/7/2012$1.17$1.21ViewN/AView Earnings Details
11/2/2011$1.41$1.39ViewN/AView Earnings Details
8/2/2011$1.43$1.53ViewN/AView Earnings Details
4/26/2011$1.30$1.38ViewN/AView Earnings Details
2/7/2011$1.29$1.35ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Becton Dickinson and (NYSE:BDX)
Current Year EPS Consensus Estimate: $8.56 EPS
Next Year EPS Consensus Estimate: $9.47 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$1.87$1.94$1.91
Q2 20164$2.26$2.39$2.33
Q3 20163$2.28$2.31$2.29
Q4 20161$2.15$2.15$2.15
Q1 20171$2.35$2.35$2.35
Q2 20171$2.31$2.31$2.31
Q3 20171$2.33$2.33$2.33
Q4 20171$2.42$2.42$2.42
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Becton Dickinson and (NYSE:BDX)
Annual Dividend:$2.64
Dividend Yield:1.50%
Payout Ratio:50.19% (Based on Trailing 12 Months of Earnings)
30.84% (Based on Current Year Consensus EPS Estimate)
27.88% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:10.10% (3 Year Average)

Dividend History for Becton Dickinson and (NYSE:BDX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/26/2016quarterly$0.661.51%9/7/20169/9/20169/30/2016
5/24/2016quarterly$0.661.58%6/7/20166/9/20166/30/2016
1/25/2016quarterly$0.661.81%3/8/20163/10/20163/31/2016
11/23/2015quarterly$0.661.75%12/8/201512/10/201512/31/2015
7/28/2015quarterly$0.601.58%9/4/20159/9/20159/30/2015
5/19/2015quarterly$0.601.69%6/5/20156/9/20156/30/2015
1/27/2015quarterly$0.601.65%3/6/20153/10/20153/31/2015
11/25/2014quarterly$0.601.7%12/8/201412/10/201412/31/2014
7/22/2014quarterly$0.551.84%9/5/20149/9/20149/30/2014
5/20/2014quarterly$0.551.88%6/5/20146/9/20146/30/2014
1/28/2014quarterly$0.552.02%3/6/20143/10/20143/31/2014
11/26/2013quarterly$0.552%12/6/201312/10/201312/31/2013
7/23/2013quarterly$0.501.91%9/5/20139/9/20139/30/2013
5/21/2013quarterly$0.501.98%6/5/20136/7/20136/28/2013
1/29/2013quarterly$0.502.35%3/6/20133/8/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Becton Dickinson and (NYSE:BDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2016Gary M CohenInsiderSell29,367$176.81$5,192,379.27View SEC Filing  
6/13/2016John E GallagherVPSell1,931$169.87$328,018.97View SEC Filing  
6/7/2016Nabil ShabshabEVPSell5,080$168.75$857,250.00View SEC Filing  
5/17/2016Jeffrey S ShermanVPSell34,373$166.27$5,715,198.71View SEC Filing  
5/13/2016Stephen SichakEVPSell12,995$166.48$2,163,407.60View SEC Filing  
5/13/2016Vincent A ForlenzaCEOSell37,933$166.17$6,303,326.61View SEC Filing  
5/10/2016James F OrrDirectorSell1,368$167.66$229,358.88View SEC Filing  
5/9/2016James C LimEVPSell5,257$165.60$870,559.20View SEC Filing  
5/6/2016Ellen R StrahlmanSVPSell3,019$163.52$493,666.88View SEC Filing  
5/6/2016Jerome V HurwitzEVPSell3,878$163.58$634,363.24View SEC Filing  
5/6/2016Rebecca W RimelDirectorSell684$163.69$111,963.96View SEC Filing  
12/14/2015Stephen SichakEVPSell8,670$152.21$1,319,660.70View SEC Filing  
12/9/2015William A KozyEVPSell15,495$154.43$2,392,892.85View SEC Filing  
12/8/2015Vincent A. ForlenzaCEOSell17,762$153.10$2,719,362.20View SEC Filing  
12/7/2015Jeffrey S ShermanVPSell7,586$153.76$1,166,423.36View SEC Filing  
12/1/2015Thomas E Polen JrEVPSell2,683$152.21$408,379.43View SEC Filing  
11/30/2015John E GallagherVPSell1,600$150.70$241,120.00View SEC Filing  
11/18/2015Jerome V. HurwitzEVPSell2,347$151.02$354,443.94View SEC Filing  
6/1/2015Stephen SichakEVPSell12,188$140.94$1,717,776.72View SEC Filing  
5/22/2015Thomas E Polen JrEVPSell3,882$142.56$553,417.92View SEC Filing  
5/21/2015Linda M TharbyEVPSell6,069$142.02$861,919.38View SEC Filing  
5/20/2015William A KozyEVPSell10,326$142.00$1,466,292.00View SEC Filing  
5/19/2015William A KozyEVPSell10,435$142.01$1,481,874.35View SEC Filing  
5/18/2015Bertram L ScottDirectorSell2,160$141.74$306,158.40View SEC Filing  
5/18/2015James C LimEVPSell3,604$141.80$511,047.20View SEC Filing  
5/15/2015Alexandre ConroyEVPSell1,291$141.37$182,508.67View SEC Filing  
5/13/2015Jeffrey S ShermanVPSell10,983$138.40$1,520,047.20View SEC Filing  
5/11/2015Jerome V HurwitzEVPSell1,197$141.43$169,291.71View SEC Filing  
5/8/2015Gary M CohenEVPSell13,490$142.90$1,927,721.00View SEC Filing  
6/12/2014Stephen SichakSVPSell1,456$118.25$172,172.00View SEC Filing  
6/10/2014Gary M CohenEVPSell12,476$119.24$1,487,638.24View SEC Filing  
6/9/2014Jeffrey S ShermanVPSell7,877$120.24$947,130.48View SEC Filing  
3/6/2014Jeffrey ShermanVPSell1,303$115.16$150,053.48View SEC Filing  
11/12/2013William KozyEVPSell9,597$108.30$1,039,355.10View SEC Filing  
11/11/2013Jeffrey ShermanVPSell4,272$107.78$460,436.16View SEC Filing  
11/11/2013Jerome HurwitzSVPSell1,151$107.78$124,054.78View SEC Filing  
11/8/2013Vincent ForlenzaCEOSell32,411$107.39$3,480,617.29View SEC Filing  
11/6/2013Henry Becton, Jr.DirectorSell2,276$106.77$243,008.52View SEC Filing  
8/23/2013Bertram ScottDirectorSell4,047$98.61$399,074.67View SEC Filing  
8/8/2013Edward DegraanDirectorSell4,436$100.03$443,733.08View SEC Filing  
8/8/2013Stephen SichakSVPSell3,431$100.13$343,546.03View SEC Filing  
8/7/2013Basil AndersonDirectorSell2,160$99.79$215,546.40View SEC Filing  
5/22/2013Henry P Becton JrDirectorSell3,117$101.86$317,497.62View SEC Filing  
5/17/2013Donna M BolesVPSell2,415$101.38$244,832.70View SEC Filing  
5/13/2013Gary M CohenEVPSell8,753$100.22$877,225.66View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Becton Dickinson and (NYSE:BDX)
DateHeadline
4-traders.com logoBecton Dickinson and : Federal Contracts Awarded by Federal Agencies in Louisiana (Aug. 27) (NYSE:BDX)
www.4-traders.com - August 27 at 3:44 PM
4-traders.com logoBecton Dickinson and : $264,705 Federal Contract Awarded to Becton, Dickinson & Co. (NYSE:BDX)
www.4-traders.com - August 27 at 8:35 AM
publicnow.com logoCurrent report no 60 / 2016 (NYSE:BDX)
www.publicnow.com - August 26 at 11:53 AM
stocksdaily.net logoBecton, Dickinson and Company (NYSE:BDX) Paying Out $-485 Million In Dividends (NYSE:BDX)
www.stocksdaily.net - August 25 at 9:13 PM
realistinvestor.com logoBecton, Dickinson and Company (NYSE:BDX) Stock Price Likely To Reach $184.583: Wall Street - RealistInvestor.com (NYSE:BDX)
www.realistinvestor.com - August 25 at 3:51 PM
marketrealist.com logoDiscussing Stryker’s Latest Valuation (NYSE:BDX)
marketrealist.com - August 25 at 8:39 AM
News IconBecton, Dickinson and Company (NYSE:BDX) from Medical Instruments & Supplies – Todays Top Gains (NYSE:BDX)
twincountynews.com - August 24 at 3:47 PM
marketrealist.com logoAnalysts’ Latest Recommendations for Stryker (NYSE:BDX)
marketrealist.com - August 24 at 12:00 PM
marketrealist.com logoAnalyzing SYK’s Capital Deployment Strategy for Investor Value (NYSE:BDX)
marketrealist.com - August 24 at 12:00 PM
News IconBecton Dickinson, Bio-Rad Laboratories Inc. and Abbott Laboratories Likely to Continue Their Dominance in The Microbiology Testing Market (NYSE:BDX)
www.prnewswire.co.in - August 23 at 3:49 PM
News IconToday's Top Gainers in the Market Becton, Dickinson and Company (NYSE:BDX) from Healthcare - The Daily Leicester (NYSE:BDX)
thedailyleicester.com - August 22 at 8:51 PM
marketrealist.com logoAnalyzing Medtronic’s Valuation before Its 1Q17 Results (NYSE:BDX)
marketrealist.com - August 22 at 8:35 AM
News IconMedical Instruments & Supplies: Becton, Dickinson and Company (NYSE:BDX) Position of the day (NYSE:BDX)
twincountynews.com - August 20 at 8:48 AM
4-traders.com logoBecton Dickinson and : BD Celebrates 60 Years In Sandy, Utah (NYSE:BDX)
www.4-traders.com - August 18 at 12:12 PM
publicnow.com logoBD Celebrates 60 Years In Sandy, Utah (NYSE:BDX)
www.publicnow.com - August 18 at 12:12 PM
News IconTop Gainers of the Day: Becton, Dickinson and Company (NYSE:BDX) from Medical Instruments & Supplies (NYSE:BDX)
twincountynews.com - August 17 at 11:59 AM
4-traders.com logoBecton Dickinson and : BD Receives FDA Clearance for New Syringe Designed for the Administration of Humulin® R U-500 Insulin (NYSE:BDX)
www.4-traders.com - August 16 at 12:31 PM
nasdaq.com logoWhich Of The Latest 13F Filers Holds Becton, Dickinson and Co.? (NYSE:BDX)
www.nasdaq.com - August 16 at 12:31 PM
finance.yahoo.com logoCowen: Becton Dickinson Well Positioned Relative To 2016, 2017 Expectations (NYSE:BDX)
finance.yahoo.com - August 15 at 3:55 PM
fidaily.com logoGeneration Investment Management Llp Sells A Lot More Becton, Dickinson and Company C (BDX) Stock Last Quarter (NYSE:BDX)
www.fidaily.com - August 15 at 11:00 AM
finance.yahoo.com logoMedtronic Launches MiniMed 630G, Expands in Diabetic Care (NYSE:BDX)
finance.yahoo.com - August 15 at 11:00 AM
News IconUpdate on Becton, Dickinson and Company (NYSE:BDX) for the day (NYSE:BDX)
twincountynews.com - August 13 at 11:58 AM
barrons.com logo[$$] Becton Dickinson Could Pump Out Steady Gains (NYSE:BDX)
www.barrons.com - August 13 at 11:58 AM
finance.yahoo.com logoTop 4 Research Reports for August 11, 2016 (NYSE:BDX)
finance.yahoo.com - August 11 at 3:53 PM
finance.yahoo.com logoTop 4 Research Reports for August 11, 2016 (NYSE:BDX)
finance.yahoo.com - August 11 at 3:53 PM
finance.yahoo.com logoBECTON DICKINSON & CO Financials (NYSE:BDX)
finance.yahoo.com - August 11 at 3:53 PM
finance.yahoo.com logoBECTON DICKINSON & CO Financials (NYSE:BDX)
finance.yahoo.com - August 11 at 3:53 PM
publicnow.com logoCurrent report no 57 / 2016 (NYSE:BDX)
www.publicnow.com - August 10 at 7:40 AM
publicnow.com logoCurrent report no 59 / 2016 (NYSE:BDX)
www.publicnow.com - August 10 at 7:40 AM
publicnow.com logoCurrent report no 58 / 2016 (NYSE:BDX)
www.publicnow.com - August 10 at 7:40 AM
tradecalls.org logoFoster Motley Inc buys $5,964,919 stake in Becton Dickinson and Co (BDX) (NYSE:BDX)
www.tradecalls.org - August 9 at 12:40 PM
News IconIs Becton, Dickinson and Company (NYSE:BDX), a large market cap stock a smart buy? (NYSE:BDX)
twincountynews.com - August 8 at 9:13 PM
News IconAnalyst Opinions on: Becton, Dickinson and Company (NYSE:BDX), Hewlett Packard Enterprise Company (NYSE:HPE) - News Oracle (NYSE:BDX)
www.newsoracle.com - August 8 at 3:50 PM
tradecalls.org logoBecton Dickinson and Company (BDX) Shares are Down -1.29% - Trade Calls (NYSE:BDX)
www.tradecalls.org - August 8 at 3:50 PM
marketrealist.com logoBecton Dickinson Stock Falls on Fiscal 3Q16 Earnings (NYSE:BDX)
marketrealist.com - August 8 at 3:50 PM
capitalcube.com logoETF’s with exposure to Becton, Dickinson & Co. : August 8, 2016 (NYSE:BDX)
www.capitalcube.com - August 8 at 3:50 PM
fidaily.com logoNeuberger Berman Group LLC Adjusts Its Investment in Becton, Dickinson and Company C (BDX) (NYSE:BDX)
www.fidaily.com - August 5 at 9:10 PM
News IconLeading stocks in today’s market: Becton, Dickinson and Company (NYSE:BDX) (NYSE:BDX)
twincountynews.com - August 5 at 9:10 PM
streetupdates.com logoAnalysts Observing Stocks Update: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , Becton, Dickinson and ... - Street Updates (NYSE:BDX)
www.streetupdates.com - August 5 at 3:48 PM
istreetwire.com logo3 Trending Stocks: Becton, Dickinson and Company (BDX), Diamond Offshore Drilling, Inc. (DO), PG&E Corporation ... - iStreetWire (NYSE:BDX)
istreetwire.com - August 5 at 12:12 PM
News IconNavient Corp (NASDAQ:NAVI) & Becton Dickinson and Co (NYSE:BDX) Traders Recap - Money News (press release) (NYSE:BDX)
www.newsismoney.com - August 5 at 12:12 PM
capitalcube.com logoBecton, Dickinson & Co. :BDX-US: Earnings Analysis: Q3, 2016 By the Numbers : August 5, 2016 (NYSE:BDX)
www.capitalcube.com - August 5 at 12:12 PM
finance.yahoo.com logoEdited Transcript of BDX earnings conference call or presentation 4-Aug-16 12:00pm GMT (NYSE:BDX)
finance.yahoo.com - August 4 at 9:33 PM
seekingalpha.com logoBecton, Dickinson & Co. (BDX) Vincent A. Forlenza on Q3 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:BDX)
seekingalpha.com - August 4 at 3:54 PM
thestreet.com logoBecton Dickinson (BDX) Stock Lower After Guidance Cut (NYSE:BDX)
www.thestreet.com - August 4 at 3:54 PM
nasdaq.com logoBecton Dickinson Tops Earnings Views, Cuts Revenue Guidance (NYSE:BDX)
www.nasdaq.com - August 4 at 12:23 PM
News IconBD lowers outlook on Q3 earnings post (NYSE:BDX)
www.massdevice.com - August 4 at 12:23 PM
twst.com logoBD – Becton, Dickinson and Company: BD Announces Results For 2016 Third Fiscal Quarter (NYSE:BDX)
www.twst.com - August 4 at 12:23 PM
seekingalpha.com logoBecton Dickinson beats on Q2 earnings but cuts revenue guidance (NYSE:BDX)
seekingalpha.com - August 4 at 9:09 AM
News IconHC Stocks Judgment: Becton Dickinson and Co (NYSE:BDX), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - share market updates (press release) (NYSE:BDX)
sharemarketupdates.com - August 3 at 3:50 PM

Social

Becton Dickinson and (NYSE:BDX) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff